A multi-centre,  randomized, double-blind,  clinical trial to evaluate the safety and efficacy of herbal medicine compared to the  standard of care for the treatment of hospitalized patients with mild to moderate cases of novel coronavirus disease (COVID-19).

 

Attachments

Your email address will not be published. Required fields are marked *

*

COVID-19 - Hope is here by NCRI

A CLINICAL EVALUATION OF EFFICACY, SAFETY IMMUNOGENICITY AND RELIABILITY OF UBV-01N- A NOVAL NATURAL PRODUCT- IN ADULT PATIENTS INFECTED WITH SARS-COV-2 (COVID-19), IN UGANDA